Ebla Khadra has over 12 years’ experience within the pharmaceutical industry in Regulatory Affairs across different regions GCC, Lebanon, and several countries  in the continent of Africa. Ebla is currently the Regulatory Affairs Specialist for Middle East region in Takeda pharmaceuticals  a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, PDT Immunology , Gastroenterology and in some markets Neuroscience and Vaccines.  .

Before joining Takeda Pharmaceuticals , Ebla was Regulatory Affairs consultant at Shire pharmaceuticals for Middle East appointed by PRA before Takeda acquisition of Shire.

Prior Shire Ebla was regulatory affairs in her home country (Syria) for over 7 years and her major achievements have been:

• Appointed as serialization champion since 2020.
• Strong Regulatory Business Partner driving for results with very high level of accountability supporting with successful launches to help our patients across our countries access to innovative products.
• She has excellent knowledge of pharma environment, regulations in Middle East and goes the extra mile embracing business dialogue